CLINICAL_TRIALS
trial_result
· 2022-10-28
Clinical Trial Update: NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia [Phase 2]
Summary
Phase 2 clinical trial update evaluating NestaCell mesenchymal stem cells for severe COVID-19 pneumonia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Azidus Brasil | Conditions: COVID-19 Pneumonia | Phase 2 | Status: COMPLETED